Screening test |
= Diabetes |
Increased risk |
Normal |
HbA1c | ≥ 6.5% | 5.7-6.4% | < 5.7% |
Fasting BG | ≥ 126 mg/dL | 100-125 mg/dL | < 100 mg/dL |
Random BG | ≥ 200 mg/dL | 140-199 mg/dL | < 140 mg/dL |
Oral glucose tolerance (75 g, testing at 2 hrs) |
≥ 200 mg/dL | 140-199 mg/dL | < 140 mg/dL |
Drug | Dose | Weight | Renal insuff. | Hypoglycemia | Side effects |
Metformin | 500 - 1000 mg BID | - | No (lactic acidosis) | - | Start at QD to minimize GI distress |
Sulfonylurea |
↑ | OK | + | ||
GLP-1 analog exenatide (Bydureon) |
|
↓ |
- | Appetite suppressant Possibly a/w pancreatitis |
|
DPP-4 inhibitor sitagliptin (Januvia) |
- |
OK |
- |
||
TZD (pioglitazone) Increase insulin sensitivity |
↑ | OK | - | Edema, CHF |
Diabetic ketoacidosis